• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用知识挖掘确定整群随机试验的样本量:群组内相关系数的贝叶斯分层模型。

Determining the sample size for a cluster-randomised trial using knowledge elicitation: Bayesian hierarchical modelling of the intracluster correlation coefficient.

机构信息

Lancashire Clinical Trials Unit, Faculty of Health and Care, University of Central Lancashire, Preston, UK.

Centre for Biostatistics, Division of Population Health, Health Services Research & Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.

出版信息

Clin Trials. 2023 Jun;20(3):293-306. doi: 10.1177/17407745231164569. Epub 2023 Apr 10.

DOI:10.1177/17407745231164569
PMID:37036110
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10262340/
Abstract

BACKGROUND

The intracluster correlation coefficient is a key input parameter for sample size determination in cluster-randomised trials. Sample size is very sensitive to small differences in the intracluster correlation coefficient, so it is vital to have a robust intracluster correlation coefficient estimate. This is often problematic because either a relevant intracluster correlation coefficient estimate is not available or the available estimate is imprecise due to being based on small-scale studies with low numbers of clusters. Misspecification may lead to an underpowered or inefficiently large and potentially unethical trial.

METHODS

We apply a Bayesian approach to produce an intracluster correlation coefficient estimate and hence propose sample size for a planned cluster-randomised trial of the effectiveness of a systematic voiding programme for post-stroke incontinence. A Bayesian hierarchical model is used to combine intracluster correlation coefficient estimates from other relevant trials making use of the wealth of intracluster correlation coefficient information available in published research. We employ knowledge elicitation process to assess the relevance of each intracluster correlation coefficient estimate to the planned trial setting. The team of expert reviewers assigned relevance weights to each study, and each outcome within the study, hence informing parameters of Bayesian modelling. To measure the performance of experts, agreement and reliability methods were applied.

RESULTS

The 34 intracluster correlation coefficient estimates extracted from 16 previously published trials were combined in the Bayesian hierarchical model using aggregated relevance weights elicited from the experts. The intracluster correlation coefficients available from external sources were used to construct a posterior distribution of the targeted intracluster correlation coefficient which was summarised as a posterior median with a 95% credible interval informing researchers about the range of plausible sample size values. The estimated intracluster correlation coefficient determined a sample size of between 450 (25 clusters) and 480 (20 clusters), compared to 500-600 from a classical approach. The use of quantiles, and other parameters, from the estimated posterior distribution is illustrated and the impact on sample size described.

CONCLUSION

Accounting for uncertainty in an unknown intracluster correlation coefficient, trials can be designed with a more robust sample size. The approach presented provides the possibility of incorporating intracluster correlation coefficients from various cluster-randomised trial settings which can differ from the planned study, with the difference being accounted for in the modelling. By using expert knowledge to elicit relevance weights and synthesising the externally available intracluster correlation coefficient estimates, information is used more efficiently than in a classical approach, where the intracluster correlation coefficient estimates tend to be less robust and overly conservative. The intracluster correlation coefficient estimate constructed is likely to produce a smaller sample size on average than the conventional strategy of choosing a conservative intracluster correlation coefficient estimate. This may therefore result in substantial time and resources savings.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f3/10262340/52ab814d8fcc/10.1177_17407745231164569-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f3/10262340/330a1b282834/10.1177_17407745231164569-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f3/10262340/83182b1387ce/10.1177_17407745231164569-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f3/10262340/52ab814d8fcc/10.1177_17407745231164569-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f3/10262340/330a1b282834/10.1177_17407745231164569-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f3/10262340/83182b1387ce/10.1177_17407745231164569-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92f3/10262340/52ab814d8fcc/10.1177_17407745231164569-fig3.jpg
摘要

背景

在整群随机试验中,组内相关系数是确定样本量的关键输入参数。由于组内相关系数的微小差异会对样本量产生很大影响,因此获得稳健的组内相关系数估计至关重要。这通常是一个问题,因为要么没有相关的组内相关系数估计值,要么由于基于小规模研究且集群数量较少,可用的估计值不够精确。参数设定不当可能导致检验效能不足或效率低下,并且潜在地不道德。

方法

我们应用贝叶斯方法来生成组内相关系数估计值,并提出了一项针对卒中后尿失禁的系统排空方案有效性的计划整群随机试验的样本量。贝叶斯层次模型用于结合其他相关试验中的组内相关系数估计值,充分利用已发表研究中可用的丰富组内相关系数信息。我们采用知识启发过程来评估每个组内相关系数估计值与计划试验设置的相关性。专家组的评审员为每个研究及其研究内的每个结果分配相关性权重,从而为贝叶斯模型的参数提供信息。为了衡量专家的表现,应用了一致性和可靠性方法。

结果

从 16 项先前发表的试验中提取了 34 个组内相关系数估计值,使用专家启发得出的聚合相关性权重在贝叶斯层次模型中进行了组合。使用来自外部来源的组内相关系数来构建目标组内相关系数的后验分布,该分布的后验中位数和 95%可信区间总结了合理的样本量值范围,为研究人员提供了信息。估计的组内相关系数确定的样本量为 450(25 个集群)至 480(20 个集群),而经典方法确定的样本量为 500-600。说明了如何使用估计后验分布的分位数和其他参数,并描述了其对样本量的影响。

结论

在未知组内相关系数中考虑不确定性,可以使用更稳健的样本量设计试验。所提出的方法提供了从各种整群随机试验设置中纳入组内相关系数的可能性,这些设置可能与计划研究不同,模型中会考虑到这种差异。通过使用专家知识来启发相关性权重,并综合外部可用的组内相关系数估计值,信息的使用比经典方法更有效,在经典方法中,组内相关系数估计值往往不够稳健且过于保守。构建的组内相关系数估计值平均而言可能产生较小的样本量,而不是选择保守的组内相关系数估计值的传统策略。因此,这可能会节省大量的时间和资源。

相似文献

1
Determining the sample size for a cluster-randomised trial using knowledge elicitation: Bayesian hierarchical modelling of the intracluster correlation coefficient.利用知识挖掘确定整群随机试验的样本量:群组内相关系数的贝叶斯分层模型。
Clin Trials. 2023 Jun;20(3):293-306. doi: 10.1177/17407745231164569. Epub 2023 Apr 10.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Intracluster correlation coefficients and coefficients of variation for perinatal outcomes from five cluster-randomised controlled trials in low and middle-income countries: results and methodological implications.低、中收入国家 5 项整群随机对照试验的围产结局的组内相关系数和变异系数:结果与方法学意义。
Trials. 2011 Jun 14;12:151. doi: 10.1186/1745-6215-12-151.
4
Power and sample size calculations for cluster randomized trials with binary outcomes when intracluster correlation coefficients vary by treatment arm.当各处理组间的组内相关系数不同时,二分类结局的群组随机试验的功效和样本量计算。
Clin Trials. 2022 Feb;19(1):42-51. doi: 10.1177/17407745211059845. Epub 2021 Dec 8.
5
Prior distributions for the intracluster correlation coefficient, based on multiple previous estimates, and their application in cluster randomized trials.基于多个先前估计值的组内相关系数的先验分布及其在整群随机试验中的应用。
Clin Trials. 2005;2(2):108-18. doi: 10.1191/1740774505cn072oa.
6
Evaluating the performance of Bayesian and restricted maximum likelihood estimation for stepped wedge cluster randomized trials with a small number of clusters.评价在小数量群组的阶乘式楔形群组随机试验中贝叶斯和限制最大似然估计的表现。
BMC Med Res Methodol. 2022 Apr 13;22(1):112. doi: 10.1186/s12874-022-01550-8.
7
Remote, real-time expert elicitation to determine the prior probability distribution for Bayesian sample size determination in international randomised controlled trials: Bronchiolitis in Infants Placebo Versus Epinephrine and Dexamethasone (BIPED) study.远程实时专家 elicitation 以确定贝叶斯样本量确定的先验概率分布在国际随机对照试验: 婴儿毛细支气管炎安慰剂与肾上腺素和地塞米松 (BIPED) 研究。
Trials. 2022 Apr 11;23(1):279. doi: 10.1186/s13063-022-06240-w.
8
Association of intracluster correlation measures with outcome prevalence for binary outcomes in cluster randomised trials.群组随机试验中,二分类结局结局的簇内相关系数与结局发生率的关系。
Stat Methods Med Res. 2021 Aug;30(8):1988-2003. doi: 10.1177/09622802211026004. Epub 2021 Jul 4.
9
Does it decay? Obtaining decaying correlation parameter values from previously analysed cluster randomised trials.它会衰减吗?从之前分析的整群随机试验中获取衰减相关参数值。
Stat Methods Med Res. 2023 Nov;32(11):2123-2134. doi: 10.1177/09622802231194753. Epub 2023 Aug 17.
10
Impact of complex, partially nested clustering in a three-arm individually randomized group treatment trial: A case study with the wHOPE trial.三臂个体随机分组治疗试验中复杂、部分嵌套聚类的影响:以 WHOPE 试验为例的案例研究。
Clin Trials. 2022 Feb;19(1):3-13. doi: 10.1177/17407745211051288. Epub 2021 Oct 24.

引用本文的文献

1
Intracluster correlation coefficients from cluster randomized trials conducted within the NCI Community Oncology Research Program (NCORP).美国国立癌症研究所社区肿瘤学研究项目(NCORP)开展的整群随机试验中的组内相关系数。
J Natl Cancer Inst Monogr. 2025 Mar 1;2025(68):65-72. doi: 10.1093/jncimonographs/lgae048.
2
Interventions for Compassion Fatigue in Healthcare Providers-A Systematic Review of Randomised Controlled Trials.医疗保健提供者同情疲劳的干预措施——随机对照试验的系统评价
Healthcare (Basel). 2024 Jan 11;12(2):171. doi: 10.3390/healthcare12020171.

本文引用的文献

1
A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials.关于确证性试验样本量推导的贝叶斯观点综述
Am Stat. 2021;75(4):424-432. doi: 10.1080/00031305.2021.1901782. Epub 2021 Apr 22.
2
Sample sizes for cluster-randomised trials with continuous outcomes: Accounting for uncertainty in a single intra-cluster correlation estimate.群组随机对照试验中连续结局的样本量:在单个组内相关系数估计中考虑不确定性。
Stat Methods Med Res. 2021 Nov;30(11):2459-2470. doi: 10.1177/09622802211037073. Epub 2021 Sep 3.
3
A framework for extending trial design to facilitate missing data sensitivity analyses.
扩展试验设计以促进缺失数据敏感性分析的框架。
BMC Med Res Methodol. 2020 Mar 17;20(1):66. doi: 10.1186/s12874-020-00930-2.
4
Methods for sample size determination in cluster randomized trials.整群随机试验中样本量确定的方法。
Int J Epidemiol. 2015 Jun;44(3):1051-67. doi: 10.1093/ije/dyv113. Epub 2015 Jul 13.
5
Identifying continence options after stroke (ICONS): a cluster randomised controlled feasibility trial.中风后失禁治疗方案识别(ICONS):一项整群随机对照可行性试验
Trials. 2014 Dec 23;15:509. doi: 10.1186/1745-6215-15-509.
6
ICIQ symptom and quality of life instruments measure clinically relevant improvements in women with stress urinary incontinence.ICIQ症状与生活质量评估工具可衡量压力性尿失禁女性临床上的相关改善情况。
Neurourol Urodyn. 2015 Nov;34(8):747-51. doi: 10.1002/nau.22657. Epub 2014 Aug 22.
7
Point-of-care cluster randomized trial in stroke secondary prevention using electronic health records.基于电子健康记录的脑卒中二级预防即时群组随机临床试验
Stroke. 2014 Jul;45(7):2066-71. doi: 10.1161/STROKEAHA.114.005713. Epub 2014 Jun 5.
8
Did a quality improvement collaborative make stroke care better? A cluster randomized trial.质量改进合作是否能改善卒中护理?一项整群随机试验。
Implement Sci. 2014 Apr 1;9(1):40. doi: 10.1186/1748-5908-9-40.
9
Effectiveness of continence promotion for older women via community organisations: a cluster randomised trial.通过社区组织提高老年女性的尿控能力:一项集群随机试验。
BMJ Open. 2013 Dec 10;3(12):e004135. doi: 10.1136/bmjopen-2013-004135.
10
A structured training programme for caregivers of inpatients after stroke (TRACS): a cluster randomised controlled trial and cost-effectiveness analysis.针对脑卒中住院患者照顾者的结构化培训方案(TRACS):一项集群随机对照试验和成本效益分析。
Lancet. 2013 Dec 21;382(9910):2069-76. doi: 10.1016/S0140-6736(13)61603-7. Epub 2013 Sep 18.